![](/img/cover-not-exists.png)
Treatment with alpha-lymphoblastoid interferon (wellferon) in high risk myelodysplastic syndromes (HR-MDS)
M.C. Petti, R. Latagliata, M.A. Aloe Spiriti, G. Avvisati, C. DeGregoris, P. Pontis, A. Spadea, F. MandelliVolume:
18
Year:
1994
Language:
english
DOI:
10.1016/0145-2126(94)90247-x
File:
PDF, 142 KB
english, 1994